These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 10666378

  • 1. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.
    Stoltzner SE, Grenfell TJ, Mori C, Wisniewski KE, Wisniewski TM, Selkoe DJ, Lemere CA.
    Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378
    [Abstract] [Full Text] [Related]

  • 2. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ.
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome.
    Gyure KA, Durham R, Stewart WF, Smialek JE, Troncoso JC.
    Arch Pathol Lab Med; 2001 Apr; 125(4):489-92. PubMed ID: 11260621
    [Abstract] [Full Text] [Related]

  • 15. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology.
    Sadowski M, Wisniewski HM, Tarnawski M, Kozlowski PB, Lach B, Wegiel J.
    Acta Neuropathol; 1999 Feb; 97(2):156-64. PubMed ID: 9928826
    [Abstract] [Full Text] [Related]

  • 16. Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.
    Veerhuis R, van der Valk P, Janssen I, Zhan SS, Van Nostrand WE, Eikelenboom P.
    Virchows Arch; 1995 Feb; 426(6):603-10. PubMed ID: 7655742
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.
    Zhou J, Fonseca MI, Pisalyaput K, Tenner AJ.
    J Neurochem; 2008 Sep; 106(5):2080-92. PubMed ID: 18624920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.